Stock Chart
ELVN
Type: SELL wallstreet
Strike: $55
Premium: $7.00
Expiry: Mar 19, 2027
Target: $57
Score: -71
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About ELVN - Enliven Therapeutics, Inc. Common Stock
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Key Statistics
More ELVN Analysis
This ELVN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ELVN's price movements with trendlines, gamma walls, and key support/resistance levels.